首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

北美 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用情況、測試類型、應用程式和最終用戶

市場調查報告書

商品編碼

1494319

北美 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用情況、測試類型、應用程式和最終用戶

North America ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 100 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美ELISA診斷測試市值為5.5469億美元，預計到2030年將達到10.0956億美元；預計2022年至2030年複合年成長率為7.8%。

動物傳染病的增加推動北美 ELISA 診斷測試市場

根據美國疾病管制與預防中心 (CDC) 的報告，光是在美國，與動物或環境有關的腸道疾病就導致 45 萬例、5,000 例住院病例和 76 例死亡。這些疾病是在人類接觸動物糞便或體液時觀察到的，透過動物接觸傳播的病原體可能對人類造成危險。此外，世界動物衛生組織發布的報告顯示，60%的人類感染是與動物有關的疾病。報告也提到，75%的新發動物疾病可以傳播給人類，每年有五種動物新興疾病。根據世界衛生組織的報告，全世界每年約有 55,000 起醫療索賠與狂犬病感染有關，其中主要是因被感染的狗咬傷而導致的兒童。此外，《動物健康》報告顯示，六種與動物相關的疾病（漢他病毒、淋巴球、脈絡膜腦膜炎病毒（LCMV）、鼠疫、沙門氏菌、鼠咬熱和兔熱病）在12 年內造成了價值800 億美元的經濟損失。在六種疾病中，僅一種與動物相關的疾病「口蹄疫」每年就給全球農民帶來高達 210 億美元的損失。乳牛中存在的持續性淋巴細胞增多症（PL）可能會在懷孕期間感染犢牛。乳牛的產奶量可能會嚴重下降，並可能感染周圍的其他動物。在這種情況下，酶聯免疫吸附測定 (ELISA) 測試最適合測試受感染牛的 PL 疾病陽性，因為它可以揭示正確的淋巴細胞計數臨床測試結果。此外，根據獸醫報告，該測試對於感染 55 天的動物的敏感性為 95%。因此，獸醫通常建議對8個月及以上的動物進行ELISA檢測。因此，動物相關疾病發生率的上升推動了對 ELISA 檢測的需求。

北美 ELISA 診斷測試市場概述

ClinMed 國際圖書館 2017 年報告顯示，「腸賈第鞭毛蟲」是美國最常見的腸道寄生蟲感染。而且，在該國，12歲以上人口中有22.5%感染「弓形蟲」。此外，近二十年來，美國人畜共患病發生率不斷上升，成為美國人口傳染病病例上升的重要原因。此外，CDC 2023報告顯示，2022年1月美國禽流感（AI）發生率呈上升趨勢。因此，為了控制美國的禽流感感染，提供了商業 ELISA 檢測試劑盒來確認任何陽性結果。因此，由於人畜共通傳染病病例較多，人類傳染病發生率不斷上升，推動了 ELISA 診斷測試在美國的採用。

北美 ELISA 診斷測試市場收入及 2030 年預測（百萬美元）

北美 ELISA 診斷測試市場細分

北美 ELISA 診斷測試市場根據採用情況、測試類型、應用程式、最終用戶和國家/地區進行細分。根據採用情況，北美 ELISA 診斷測試市場分為人類和獸醫市場。 2022 年，人類細分市場將佔據更大的市場佔有率。

就測試類型而言，北美ELISA診斷測試市場分為夾心ELISA、間接ELISA、競爭性ELISA以及多重攜帶式ELISA。 2022 年，間接 ELISA 細分市場佔據最大的市場佔有率。

根據應用，北美 ELISA 診斷測試市場分為自體免疫疾病、傳染病、癌症診斷、蛋白質定量等。 2022 年，傳染病領域佔據最大的市場佔有率。

按最終用戶分類，北美 ELISA 診斷測試市場分為醫院和診斷中心、製藥和生物技術公司、獸醫醫院和診斷實驗室等。 2022 年，醫院和診斷中心細分市場佔據最大的市場佔有率。

根據國家/地區，北美 ELISA 診斷測試市場分為美國、加拿大和墨西哥。 2022 年，美國主導北美 ELISA 診斷測試市場。

Bio-Rad Laboratories Inc.、Idex Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Pictor Ltd.、DiaSorin SpA、Elabscience Biotechnology Inc. 與 Bio-Techne Corp是北美ELISA 診斷測試市場上的一些領先公司。

According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals or environments account for 450,000 case of illnesses, 5,000 hospitalizations, and 76 deaths among humans in the US alone. These illnesses are observed in humans in contact with animal feces or body fluids, and the pathogens transmitted through animal contact can prove dangerous for humans. Additionally, the World Organization for Animal Health published a report revealing that 60% of human infections comprise animal-related diseases. It also mentioned that 75% of emerging animal diseases can be transmitted to humans, and there are five emerging diseases among animals annually. Every year, about 55,000 healthcare claims are associated with rabies infection worldwide, comprising mainly children due to infected dog bites as per the WHO report. Further, the Health for Animals report reveals that six animal-related diseases (Hantavirus, Lymphocytic, Choriomeningitis virus (LCMV), plague, salmonella, rat bite fever, and tularemia) caused economic losses worth US$ 80 billion within 12 years. Among six, just one animal-related disease, "Foot and Mouth," costs farmers up to US$ 21 billion globally every year. The persistent lymphocytosis (PL) present among cows can infect their calves during pregnancy. Cows can suffer from serious milk production declines and may infect other surrounding animals. In this scenario, Enzyme-Linked Immunosorbent Assay (ELISA) test is best suited to test infected cow's positive for PL disease as it reveals proper lymphocyte count clinical results on testing. Further, the test is reported by veterinarian to be 95% sensitive for animals infected with 55 days of infection. Therefore, ELISA test is commonly recommended by veterinarian for animals aged 8 months and above. Thus, rising incidence of animal-associated diseases propels the demand for ELISA tests.

North America ELISA Diagnostics Tests Market Overview

The ClinMed International Library 2017 report reveals that "Giardia Intestinalis" is the most common intestinal parasitic infection in the US. Moreover, in the country, 22.5% of the population over 12 years of age gets infected with "Toxoplasma Gondii". Further, in the last two decades, there has been a rise in the incidence of zoonotic diseases in the US, becoming a significant cause of rising infectious disease cases among the US population. Additionally, the CDC 2023 report reveals that the incidence of avian influenza (AI) was on the rise in the US in January 2022. It stated that 59,031,321 birds were affected due to AI in the US as per the CDC report. Therefore, to control AI infections in the US, commercial ELISA test kits were made available to confirm any positives. Thus, rising incidences of infectious diseases among humans due to high zoonotic disease cases boost the adoption of ELISA diagnostic tests in the US.

North America ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

North America ELISA Diagnostics Tests Market Segmentation

The North America ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the North America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the North America ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the North America ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the North America ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the North America ELISA diagnostics tests market is segmented into the US, Canada, and Mexico. The US dominated the North America ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the North America ELISA diagnostics tests market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
- 1.2.1 North America ELISA Diagnostic Tests Market - by Adoption
- 1.2.2 North America ELISA Diagnostic Tests Market - by Test Type
- 1.2.3 North America ELISA Diagnostic Tests Market - by Application
- 1.2.4 North America ELISA Diagnostic Tests Market - by End User
- 1.2.5 North America ELISA Diagnostic Tests Market - by Country

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America ELISA Diagnostic Test Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Infectious Diseases Among Animals
- 4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
- 4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
- 4.3.1 Innovative Product Launches
4.4 Future Trends
- 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - North America Market Analysis

5.1 Overview
5.2 North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

6.1 Overview
6.2 North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
- 6.3.1 Overview
- 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
- 6.4.1 Overview
- 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
- 7.3.1 Overview
- 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
- 7.4.1 Overview
- 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
- 7.5.1 Overview
- 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
- 7.6.1 Overview
- 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
- 8.3.1 Overview
- 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
- 8.4.1 Overview
- 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
- 8.5.1 Overview
- 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
- 8.6.1 Overview
- 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America: ELISA Diagnostic Tests Market
- 10.1.1 North America: ELISA Diagnostic Tests Market, by Country
  - 10.1.1.1 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Bio-Rad Laboratories Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Idexx Laboratories Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Danaher Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pictor Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 DiaSorin SpA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Elabscience Biotechnology Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Overview
- 12.9.4 SWOT Analysis
- 12.9.5 Key Developments
12.10 Bio-Techne Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. Following is a list of zoonotic disease outbreaks spread between animals and people.
Table 4. US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 5. US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. US ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. US ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 16. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 17. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 18. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
Figure 5. North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in ELISA diagnostics test Market